85773902 - ACTAVIS

Information

  • Trademark
  • 85773902
  • Serial Number
    85773902
  • Filing Date
    November 07, 2012
    12 years ago
  • Transaction Date
    February 12, 2018
    6 years ago
  • Status Date
    February 12, 2018
    6 years ago
  • Published for Opposition Date
    August 06, 2013
    11 years ago
  • Location Date
    July 29, 2016
    8 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    LEE, JANET H
  • Attorney Name
    Gabrielle S. Roth
    Law Office Assigned Location Code
    N60
  • Owners
Mark Drawing Code
3000
Mark Identification
ACTAVIS
Case File Statements
  • CC0000: The color(s) green and blue is/are claimed as a feature of the mark.
  • DM0000: The mark consists of the word "ACTAVIS" displayed in the color green, below the letters "a" and "w", which appear in an intertwined, fanciful lettering style displayed in the colors green and blue that resembles a horizontal zig-zag line or a coil.
  • GS0011: Chemicals used in industry and science, namely, active chemical ingredients for use in the manufacture of pharmaceuticals, chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes; chemical preparations for use in industry
  • GS0031: Soaps; Perfumery; Essential Oils; Cosmetics, namely, cosmetic preparations for skin care, cosmetic preparations for body care, cosmetic preparations for bath and shower, cosmetic creams, lotions, and ointments and gels for skin care, cosmetic skin fresheners and toners, cosmetic preparations for the hair and scalp, and hair lotions; Dentifrices, namely, anti-cavity dental rinses, mouth rinses and mouth washes, cosmetic preparations for the care of mouth and teeth
  • GS0051: Pharmaceutical preparations for the prevention and treatment of alimentary tract and metabolic diseases and disorders, dermatological diseases and disorders, genito-urinary and sexual diseases and disorders, musculo-skeletal system diseases and disorders, nervous system diseases and disorders, respiratory system diseases and disorders, cardio-vascular diseases and disorders specifically excluding tissue plasminogen activators; pharmaceutical preparations for the prevention and treatment of sensory organ diseases and disorders, systemic hormonal pharmaceutical preparations and substances, pharmaceuticals, namely, anti-infectives, pharmaceutical preparations, namely, antineoplastic and immunomodulating agents, antiparasitic preparations and substances; contraceptives; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations, pharmaceutical preparations and substances for the treatment of premenstrual syndrome, post natal depression, fluctuating hormone levels, pharmaceutical preparations and substances for infertility disorders, pharmaceutical preparations and substances for in vitro fertilization (ivf); pharmaceutical preparations in the nature of medicated dental rinses, mouth rinses, mouthwashes, dental lozenges, dental tablets and medicated chewing gum; dental wax; pharmaceutical preparations in the nature of pregnancy test kits, ovulation test kits and in-vitro ovulation prediction test kits all for home use; pharmaceutical preparations in the nature of diagnostic test kits for home use for detecting urinary tract infections, for detecting menopause, for detecting vaginal pH balances and for detecting sexually-transmitted diseases; pharmaceutical preparations for skin care; all the foregoing specifically excluding tissue plasminogen activators
  • GS0411: Education services, namely, conducting conferences, seminars, webinars, video case studies, classes and workshops in the fields of healthcare, women's health, pharmaceuticals and medicine, pharmaceutical research and development
  • GS0421: Scientific and technological services, namely, consulting in the field of pharmaceuticals pertaining to biotechnology, product evaluation, diagnostics, testing and inspection; pharmaceutical research and development; industrial analysis and research services in the field of pharmaceuticals and chemical analysis
Case File Event Statements
  • 2/12/2018 - 6 years ago
    57 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Type: MAB6
  • 2/12/2018 - 6 years ago
    56 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 7/27/2017 - 7 years ago
    55 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/26/2017 - 7 years ago
    54 - EXTENSION 4 GRANTED Type: EX4G
  • 7/7/2017 - 7 years ago
    53 - EXTENSION 4 FILED Type: EXT4
  • 7/20/2017 - 7 years ago
    52 - NOTICE OF REVIVAL - E-MAILED Type: NREV
  • 7/19/2017 - 7 years ago
    51 - EXTENSION RECEIVED WITH TEAS PETITION Type: TPEX
  • 7/19/2017 - 7 years ago
    50 - PETITION TO REVIVE-GRANTED Type: PETG
  • 7/19/2017 - 7 years ago
    49 - TEAS PETITION TO REVIVE RECEIVED Type: PROA
  • 7/19/2017 - 7 years ago
    48 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 2/22/2017 - 7 years ago
    47 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 1/6/2017 - 7 years ago
    46 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/4/2017 - 7 years ago
    45 - EXTENSION 3 GRANTED Type: EX3G
  • 1/4/2017 - 7 years ago
    44 - EXTENSION 3 FILED Type: EXT3
  • 1/4/2017 - 7 years ago
    43 - TEAS EXTENSION RECEIVED Type: EEXT
  • 8/2/2016 - 8 years ago
    42 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/1/2016 - 8 years ago
    41 - EXTENSION 2 GRANTED Type: EX2G
  • 6/28/2016 - 8 years ago
    40 - EXTENSION 2 FILED Type: EXT2
  • 7/29/2016 - 8 years ago
    39 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 6/28/2016 - 8 years ago
    38 - TEAS EXTENSION RECEIVED Type: EEXT
  • 11/25/2015 - 8 years ago
    37 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/23/2015 - 8 years ago
    36 - EXTENSION 1 GRANTED Type: EX1G
  • 11/23/2015 - 8 years ago
    35 - EXTENSION 1 FILED Type: EXT1
  • 11/23/2015 - 8 years ago
    34 - TEAS EXTENSION RECEIVED Type: EEXT
  • 7/7/2015 - 9 years ago
    33 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 2/10/2015 - 9 years ago
    32 - TTAB RELEASE CASE TO TRADEMARKS Type: TMBN
  • 2/10/2015 - 9 years ago
    31 - OPPOSITION TERMINATED NO. 999999 Type: OP.T
  • 2/10/2015 - 9 years ago
    30 - OPPOSITION DISMISSED NO. 999999 Type: OP.D
  • 1/30/2014 - 10 years ago
    29 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I
  • 8/16/2013 - 11 years ago
    28 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 8/6/2013 - 11 years ago
    27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/6/2013 - 11 years ago
    26 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/17/2013 - 11 years ago
    25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/3/2013 - 11 years ago
    24 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 7/2/2013 - 11 years ago
    23 - ASSIGNED TO LIE Type: ALIE
  • 7/1/2013 - 11 years ago
    22 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/14/2013 - 11 years ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/13/2013 - 11 years ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/13/2013 - 11 years ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/13/2013 - 11 years ago
    18 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 5/30/2013 - 11 years ago
    17 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 5/30/2013 - 11 years ago
    16 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 3/20/2013 - 11 years ago
    15 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 2/5/2013 - 11 years ago
    14 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 2/5/2013 - 11 years ago
    13 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 2/5/2013 - 11 years ago
    12 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 2/4/2013 - 11 years ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/4/2013 - 11 years ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/4/2013 - 11 years ago
    9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/3/2012 - 11 years ago
    8 - NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Type: GEAN
  • 12/3/2012 - 11 years ago
    7 - EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Type: GEAP
  • 12/3/2012 - 11 years ago
    6 - COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY Type: EPEN
  • 12/3/2012 - 11 years ago
    5 - EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Type: CPEA
  • 11/28/2012 - 11 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/15/2012 - 11 years ago
    3 - NOTICE OF DESIGN SEARCH CODE MAILED Type: MDSC
  • 11/14/2012 - 11 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 11/10/2012 - 11 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP